UpHealth (NYSE:UPH) Research Coverage Started at Lake Street Capital

Stock analysts at Lake Street Capital initiated coverage on shares of UpHealth (NYSE:UPH) in a research note issued on Monday, The Fly reports. The brokerage set a “buy” rating on the stock.

UPH has been the topic of a number of other research reports. Colliers Securities reissued a “buy” rating on shares of UpHealth in a report on Tuesday, August 10th. Northland Securities initiated coverage on shares of UpHealth in a research note on Tuesday, July 13th. They set an “outperform” rating and a $13.00 target price on the stock. Zacks Investment Research upgraded shares of UpHealth from a “sell” rating to a “hold” rating in a research note on Wednesday, September 15th. Finally, Oppenheimer initiated coverage on shares of UpHealth in a research note on Thursday, July 22nd. They set an “outperform” rating and a $12.00 target price on the stock. One analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, UpHealth currently has an average rating of “Buy” and a consensus price target of $12.67.

UPH opened at $1.82 on Monday. The company has a current ratio of 0.96, a quick ratio of 0.94 and a debt-to-equity ratio of 0.16. The business has a 50 day simple moving average of $3.94. UpHealth has a 12-month low of $1.61 and a 12-month high of $12.12.

UpHealth (NYSE:UPH) last posted its quarterly earnings data on Thursday, August 12th. The company reported ($0.39) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.06) by ($0.33). The company had revenue of $31.88 million for the quarter, compared to the consensus estimate of $38.44 million. On average, equities research analysts predict that UpHealth will post -0.6 earnings per share for the current year.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Highbridge Capital Management LLC bought a new stake in shares of UpHealth during the second quarter valued at approximately $61,000. Paloma Partners Management Co bought a new stake in shares of UpHealth during the second quarter valued at approximately $73,000. Morgan Stanley bought a new stake in shares of UpHealth during the second quarter valued at approximately $75,000. Cubist Systematic Strategies LLC bought a new stake in shares of UpHealth during the second quarter valued at approximately $78,000. Finally, Commonwealth Equity Services LLC bought a new stake in shares of UpHealth during the second quarter valued at approximately $97,000. Institutional investors own 8.40% of the company’s stock.

About UpHealth

UpHealth, Inc operates as a digital health services company. The company provides patient-centric digital health platform and tech-enabled services to manage health and integrate care. It serves empowering providers, health systems, health plans and governments, employers, and educational institutions.

Further Reading: What are the risks of holding treasury bonds?

The Fly logo

Receive News & Ratings for UpHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UpHealth and related companies with MarketBeat.com's FREE daily email newsletter.